[Results of a trial of a coronary therapeutic agent, Adalat (author's transl)].
This report concerns data on 54 patients with coronary heart disease. With a 4-6 week treatment with 3 X 1 capsule Adalat daily, the attacks of angina pectoris fell from 1-7 daily to 1-2 per week. In more than 50% of the subjects, no more attacks occurred. Nitroglycerine consumption fell accordingly. Ergometry carried out on 12 patients at the end of the study showed an increased load resistance of 20 to 30 W in each case, compared with the initial value. The preparation was well tolerated.
D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000627:therapeutic use*; D005996:Nitroglycerin / Q000008:administration & dosage; D011725:Pyridines / Q000627:therapeutic use*
D011725:Pyridines; D005996:Nitroglycerin; D009543:Nifedipine
Ergebnisse einer Prüfung des Koronartherapeutikums Adalat